ALLSCRIPTS INC /IL
10-Q, EX-27, 2000-11-14
DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES
Previous: ALLSCRIPTS INC /IL, 10-Q, 2000-11-14
Next: FUTURELINK CORP, 10QSB, 2000-11-14



<TABLE> <S> <C>

<PAGE>

<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                         DEC-31-2000
<PERIOD-START>                            JAN-01-2000
<PERIOD-END>                              SEP-30-2000
<CASH>                                         77,657
<SECURITIES>                                   23,391
<RECEIVABLES>                                  18,165
<ALLOWANCES>                                    4,266
<INVENTORY>                                     5,315
<CURRENT-ASSETS>                              123,015
<PP&E>                                         18,387
<DEPRECIATION>                                  7,526
<TOTAL-ASSETS>                                320,641
<CURRENT-LIABILITIES>                          14,801
<BONDS>                                             0
                               0
                                         0
<COMMON>                                          294
<OTHER-SE>                                    305,546
<TOTAL-LIABILITY-AND-EQUITY>                  320,641
<SALES>                                        36,601
<TOTAL-REVENUES>                               36,601
<CGS>                                          28,743
<TOTAL-COSTS>                                  60,083
<OTHER-EXPENSES>                                    0
<LOSS-PROVISION>                                    0
<INTEREST-EXPENSE>                            (5,702)
<INCOME-PRETAX>                              (46,523)
<INCOME-TAX>                                        0
<INCOME-CONTINUING>                          (46,523)
<DISCONTINUED>                                  4,436
<EXTRAORDINARY>                                     0
<CHANGES>                                           0
<NET-INCOME>                                 (42,087)
<EPS-BASIC>                                      1.54
<EPS-DILUTED>                                    1.54


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission